Biopsy Needle Market Report 2026

Biopsy Needle Market Overview

• Biopsy Needle market size has reached to $1.41 billion in 2025 • Expected to grow to $2.06 billion in 2030 at a compound annual growth rate (CAGR) of 7.9% • Growth Driver: Increasing Demand For Minimally Invasive Procedures Fueling The Growth Of The Market Due To Faster Recovery And Reduced Patient Trauma • Market Trend: New Core Biopsy Device Offers Consistent High-Quality Tissue Samples • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biopsy Needle Market?

A biopsy needle is a specialized medical instrument used to extract tissue samples from the body for diagnostic examination, typically under imaging guidance. It is commonly used to detect cancer, infections, or other abnormalities in organs and tissues. The main purpose of a biopsy needle is to obtain a minimally invasive, accurate sample for histopathological analysis. The main types of biopsy needle are disposable and non-disposable. A disposable biopsy needle refers to a single-use medical device designed to collect tissue samples for diagnostic examination and is discarded after one procedure to prevent cross-contamination. These products include needle-based biopsy guns, vacuum-assisted biopsy devices, fine needle aspiration biopsy devices, and core needle biopsy devices used in both image-guided and non-image-guided procedures. It is used for various applications such as cancer or tumors of the breast, lung, prostate, colon, stomach, liver, rectum, cervix uteri, and others, serving end users catering hospitals and surgical centers, diagnostic clinics and pathology laboratories, ambulatory care centers, and research and academic institutes.

What Is The Biopsy Needle Market Growth Forecast?

The biopsy needle market size is expected to see strong growth in the next few years. It will grow to $2.06 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to technological advancements in image-guided and vacuum-assisted devices, development of innovative disposable needle designs, expansion of diagnostic clinics and pathology laboratories, rising investment in research and academic institutes, integration of ai and digital tools for precision diagnostics. Major trends in the forecast period include increasing adoption of image-guided biopsy procedures, rising preference for disposable biopsy needles, growth in minimally invasive diagnostic techniques, expansion of cancer and tumor screening programs, enhanced focus on patient safety and sterility standards.

Global Biopsy Needle Market Segmentation

1) By Usage: Disposable, Non-Disposable 2) By Product: Needle Based Biopsy Guns, Vacuum-Assisted Biopsy Devices, Fine Needle Aspiration Biopsy Devices, Core Needle Biopsy Devices 3) By Procedure: Image-Guided Procedures, Non-Image-Guided Procedures 4) By Application: Cancer Or Tumor, Breast, Lung, Prostate, Colon, Stomach, Liver, Rectum, Cervix Uteri, Other Applications 5) By End-User: Hospitals And Surgical Centers, Diagnostic Clinics And Pathology Laboratories, Ambulatory Care Centers, Research And Academic Institutes Subsegments: 1) By Disposable: Coaxial Biopsy Needles, Chiba Needles, Jamshidi Needles 2) By Non-Disposable: Reusable Tru-Cut Biopsy Needles, Reusable Menghini Needles, Reusable Francine Needles

What Is The Driver Of The Biopsy Needle Market?

The increasing demand for minimally invasive procedures is expected to propel the growth of the biopsy needle market going forward. Minimally invasive procedures refer to medical interventions performed through small incisions or openings, reducing patient trauma and recovery time. The demand for minimally invasive surgical procedures is increasing due to their ability to offer shorter recovery times, reduced risks of complications, less pain, and smaller scars, making them more appealing to patients seeking quicker and safer treatment options. Biopsy needles aid in minimally invasive procedures by enabling precise tissue sampling, reducing the need for surgical intervention. They support quicker diagnoses and recovery times, improving patient comfort and procedural efficiency. For instance, in November 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, the total number of cosmetic minimally invasive procedures reached 25,442,640 in 2023, marking a 7% increase from 23,672,269 in 2022. Therefore, the increasing demand for minimally invasive procedures is driving the growth of the biopsy needle industry.

Key Players In The Global Biopsy Needle Market

Major companies operating in the biopsy needle market are Cardinal Health Inc., Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., Cook Medical, Halma plc, Merit Medical Systems Inc., ConMed Corporation, Devicor Medical Products Inc., Shandong Weigao Group Medical Polymer Company Limited, Remington Medical Inc., Advin Health Care, Nikotech Healthcare Pvt. Ltd., Argon Medical Devices Inc., Geotek Medical Products Co. Ltd., Biomedical Srl, Hakko Co. Ltd., INRAD Inc.

Global Biopsy Needle Market Trends and Insights

Major companies operating in the biopsy needle market are focusing on developing technologically advanced products, such as semi-automatic core biopsy instruments, to enhance precision and ease of tissue sampling in minimally invasive procedures. Semi-automatic core biopsy instruments are medical devices that use a spring-loaded mechanism to quickly and accurately collect tissue samples with minimal manual effort during a biopsy procedure. For instance, in May 2023, Argon Medical Devices Inc., a US-based medical device manufacturer, launched the SuperCore Advantage semi-automatic biopsy instrument. It is a semi-automatic, disposable core biopsy needle that provides consistent, high-quality tissue samples for accurate diagnosis. It features an ergonomic design, a sharp cutting edge for clean specimen retrieval, and an adjustable throw length to accommodate different lesion depths. The device also enhances biopsy precision while reducing patient discomfort, offering improved diagnostic options for patients.

What Are Latest Mergers And Acquisitions In The Biopsy Needle Market?

In October 2023, Halma plc, a UK-based global life-saving technology company, acquired AprioMed for an undisclosed amount. Through this acquisition, Halma aims to enhance its cancer diagnosis capabilities by integrating AprioMed’s biopsy needle products for minimally invasive procedures. AprioMed AB is a Sweden-based medical device company that designs and manufactures biopsy needles to help diagnose conditions such as cancer, complementing Halma’s IZI Medical Products portfolio.

Regional Outlook

North America was the largest region in the biopsy needle market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Biopsy Needle Market?

The biopsy needle market consists of sales of core needle biopsy devices, Menghini needles, and Francine needles. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.